This week, the top stories in managed care included the president-elect's picks for HHS and CMS, the American Diabetes Association addressed psychosocial care for patients with diabetes, and the American Society of Clinical Oncology released criteria on creating clinical pathways.
In an increasingly tech-focused world, the use of phones, tablets, and computes, combined with social media sites, have allowed patients to find the emotional and social interactions they need when dealing with their care, said Mike Payne, MBA, MSci, chief healthcare development officer at Omada Health.
The study found that avoiding 3 key risk factors-diabetes, obesity, and hypertension-by age 45, greatly increased the likelihood of avoiding heart failure through the end of life.
The study found young adults had the lowest device uptake, as well as highest distress levels and the highest A1C.
The proposal from CMS may make it difficult for groups that have been providing the DPP to take part in Medicare reimbursement.
Early results published Tuesday were first presented this summer at the meeting of the American Diabetes Association.
The statement calls for delivery behavioral health services through a collaborative model when possible, both to share electronic health data and offer convenience and continuity for patients.
This week, the top managed care stories included the FDA's approval of rival combination therapies for type 2 diabetes, the American Medical Association issued mHealth guidelines, and a study found the dementia rate declining.
While smoking has long been known to aggravate diabetes, the new study shows just how deadly the habit is for those with the chronic condition.
Some estimates put the market for insulin and GLP-1 combination therapy at $1 billion.
A study of older Americans has found that the prevalence of dementia has decreased significantly, from 11.6% in 2000 to 8.8% in 2012. It cited increased average educational attainment and improved diabetes treatments as factors that could explain the drop in dementia rates.
The matchstick-size pump has been heralded as a game changer in addressing the biggest problem in diabetes care: medication adherence.
Earlier this month, 2 members of Congress called for the Justice Department and the Federal Trade Commission to examine whether the major insulin manufacturers are coordinating on prices.
A review of our peer-reviewed research in the healthcare and mainstream press.
Public health officials scrutinize obesity rates among young children as an indicator of how efforts to combat the epidemic are faring overall.
Studies of the effect of diet soda on diabetes and obesity have produced mixed results.
A study of a pair of large databases shows a strong link between obesity and heart failure.
The results point to the need for more study on the effects of long-duration blood pressure treatment to prevent cognitive decline, especially in the highest risk patients.
The results from a wide-ranging public health effort in Howard County, Maryland, show a decline in sugary beverage consumption nearly on par with early results from Berkeley, California, which passed the nation's first soda tax.
A new wearable medical device helped patients replace a stress response that is lost for those with type 2 diabetes.
Three of the 4 cities to pass taxes on soda are in Northern California, not far from Berkeley, which passed the nation's first soda tax in 2014.
The findings come as epidemiologists have noted rising rates of liver cancer amid falling rates of cancer generally.
A spokesman for The Obesity Society said that lack of payer coverage for obesity may discourage physicians from recording body mass index and making a formal diagnosis.
Patient-centered medical homes may improve the performance of process measures of care for patients with type 2 diabetes, including glycated hemoglobin tests, cholesterol tests, foot examination, dilated eye examination, flu vaccination, and adherence to oral hypoglycemic agents during 1 year of follow-up.
CMS' decision to pay for the Diabetes Prevention Program marks a shift in payment models from one that originally only paid for the screening and treatment of diabetes to one that now weighs prevention just as seriously in diabetes care, Mike Payne, MBA, MSci, chief healthcare development officer at Omada Health.